Caplight Directory>Companies>Bioptimus-preview>Bioptimus


Bioptimus

Bioptimus

Private
Paris, Île-de-FranceHealthcare & Life Scienceshttps://www.bioptimus.com

Last Round

Series A

Jan 14, 2025

Total Funding Raised

$117M

Momentum Score

75 /100

Company Overview

Bioptimus is a biotechnology and artificial intelligence company that develops a universal AI foundation model to enhance scientific research and drive biotechnological innovation by transforming multiscale biological data into actionable insights.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, ML Platforms, Medical AI, Clinical Trials

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting, Data as a Service

AI Layer

Foundation

Keywords

foundation model for biologyChatGPT for biologymultimodal AIAI for drug discoverygenerative biologyfrontier AI labcomputational biologyhistology AIbiology simulationAI platformspatial biologyclinical trial AIproprietary biological data

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Bioptimus Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Bioptimus Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AJan 14, 2025
Series AJan 14, 2025
SeedFeb 20, 2024
View all Funding Rounds

Bioptimus Investors

Notable investors and investment history

InvestorRounds
Boom Capital VenturesSeries A
HV FundSeries A
NJF CapitalSeed
Andera PartnersSeries A
Top Harvest CapitalSeed
Pomifer Capital PartnersSeries A
Sofinnova PartnersSeries A, Seed
View all Investors

Bioptimus Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Bioptimus Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Bioptimus's valuation, stock price, and market status.

Firmographic Details

HeadquartersParis, Île-de-France
Employee Range38
Year Founded2024
Last FundingJan 14, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.